A QbD Framework for Efficient Technology Transfer in Biologics Manufacturing

Technology transfer from clients to contract development and manufacturing organizations is a complicated process and inclusion of scale-up and scale-down strategies brings additional complexity. These complexities can lead to extended development timelines and significant resource utilizations to meet regulatory compliance. This manuscript presents the implementation of Quality by Design (QbD) principles as a systematic framework to mitigate these challenges and improve technology transfer efficiency. Here I provide a strategic approach to integrate QbD across five key stages of technology transfer: Scope of Work Development, Information Transfer and Failure Mode and Effects Analysis, Technology Transfer and Pilot Runs, Pre-Production Activities, and cGMP Production. By adopting this QbD-driven methodology, companies can achieve more effective knowledge transfer, develop scalable and reproducible processes, and ensure consistent product quality in alignment with regulatory standards.

Authors

Institutions

Publication Details

Journal
PDA Journal of Pharmaceutical Science and Technology
Published
2026-01-30
DOI
https://doi.org/10.5731/pdajpst.2025-000074.1
Primary Topic
Technology Assessment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A QbD Framework for Efficient Technology Transfer in Biologics Manufacturing

Dogan Ornek
PDA Journal of Pharmaceutical Science and Technology
Technology Assessment and Management
article

A QbD Framework for Efficient Technology Transfer in Biologics Manufacturing

Dogan Ornek
article en

Abstract

Technology transfer from clients to contract development and manufacturing organizations is a complicated process and inclusion of scale-up and scale-down strategies brings additional complexity. These complexities can lead to extended development timelines and significant resource utilizations to meet regulatory compliance. This manuscript presents the implementation of Quality by Design (QbD) principles as a systematic framework to mitigate these challenges and improve technology transfer efficiency. Here I provide a strategic approach to integrate QbD across five key stages of technology transfer: Scope of Work Development, Information Transfer and Failure Mode and Effects Analysis, Technology Transfer and Pilot Runs, Pre-Production Activities, and cGMP Production. By adopting this QbD-driven methodology, companies can achieve more effective knowledge transfer, develop scalable and reproducible processes, and ensure consistent product quality in alignment with regulatory standards.

PDA Journal of Pharmaceutical Science and Technology
Boston Scientific (United States) (US)
Industry, innovation and infrastructure
Openalex Percentile: Top 78%
Technology Assessment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A QbD Framework for Efficient Technology Transfer in Biologics Manufacturing — Dogan Ornek · PDA Journal of Pharmaceutical Science and Technology (2026) | TGRS Research Map | TGRS